When OC-derived from healthy individuals were used to expand both healthy individuals and cancer patients’ T cells, OC-expanded T cells also demonstrated higher percentages of CD8+ T cell expansion from both healthy and patient derived T cells, which were higher than those seen from those obtained initially from the peripheral blood (Fig. 3B–E). This evidence concerns the gene CD8A and cancer.